Abrdn PLC Prestige Consumer Healthcare Inc. Transaction History

Abrdn PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$26.79 - $31.72 $7.77 Million - $9.2 Million	-290,170 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$29.28 - $41.29 $23.6 Million - $33.2 Million	-804,737 Reduced 73.5%	290,170 $8.81 Million
Q3 2018 Nov 13, 2018	BUY	$34.44 - $39.35 $2.24 Million - $2.56 Million	65,155 Added 6.33%	1,094,907 $41.5 Million
Q2 2018 Aug 09, 2018	SELL	$28.49 - $38.41 $5.61 Million - $7.57 Million	-197,052 Reduced 16.06%	1,029,752 $39.5 Million
Q1 2018 May 15, 2018	SELL	$32.94 - $46.03 $1.9 Million - $2.66 Million	-57,683 Reduced 4.49%	1,226,804 $41.4 Million
Q4 2017 Feb 12, 2018	BUY	$40.63 - $50.91 $8.28 Million - $10.4 Million	203,809 Added 18.86%	1,284,487 $57 Million
Q3 2017 Nov 14, 2017	BUY	$48.69 - $53.63 $52.6 Million - $58 Million	1,080,678	1,080,678 $54.1 Million

338

50.2M

6.3K

Ticker PBH
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,762,600
Market Cap $3.91B
Description
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's an...

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

Stay updated on Abrdn PLC with notifications on news.